VGNT: Adjusted EBITDA grew 10.9%; FY26 sales and free cash flow guidance midpoints rose

What happened

Versigent reported Q3 net sales rose 7.2% and adjusted EBITDA, a measure of operating earnings, increased 10.9%; adjusted growth was about 1% amid weaker auto production. The company raised its FY26 net sales and free cash flow guidance midpoints and declared a $0.13 quarterly dividend.

Confirmed

Global impact / market context

Higher guidance midpoints indicate management now expects stronger full-year sales and cash generation than before, while the dividend returns some cash to shareholders. However, the much slower adjusted growth amid weaker auto production points to an industry headwind that could limit future gains.

Analyst inference

The results show a gap between reported growth and adjusted growth: sales rose 7.2% and adjusted EBITDA rose 10.9%, but adjusted growth was about 1% amid weaker auto production. That makes the raised full-year outlook important, though it does not remove production-related uncertainty.

Analyst inference

What to watch

1. Compare later quarterly sales and adjusted EBITDA with the raised FY26 guidance midpoints to see whether stronger reported growth translates into continued progress. Analyst inference
2. Watch whether auto production weakness persists; the article links it to about 1% adjusted growth, so continued weakness could constrain sales and earnings. Analyst inference
3. Check whether Versigent pays the declared $0.13 quarterly dividend and generates the free cash flow underpinning its raised FY26 guidance midpoint. Analyst inference

Evidence

• Original source link unavailable